Atherosclerotic Cardiovascular Disease

In last week’s top story in cardiology, a cross-sectional analysis found that cannabis use was significantly associated with increased odds of having a high atherosclerotic CVD risk.

Elevated atherosclerotic CVD risk was linked to cannabis use in a study published in the American Journal of Cardiology.

Last week’s top story in cardiology was about the FDA approval of Leqvio for LDL lowering. According to the manufacturer, the drug is administered twice a year after the initial dose and a follow-up dose at 3 months.

Aspirin use for primary atherosclerotic CVD prevention continues to be prevalent in adults aged 70 years or older despite contrary guideline recommendations, according to data published in the American Journal of Preventive Cardiology.

A retrospective analysis published in JAMA Cardiology found significant improvement in atherosclerotic CVD risk prediction among participants with former smoking, pack-years and years since quitting.

Infertility was independently associated with an increased risk for atherosclerotic CVD among nulliparous women, a longitudinal cohort study showed.

CV events with degarelix (Firmagon, Ferring Pharmaceuticals) or leuprolide in patients with advanced prostate cancer and CVD.

Although various studies have established the prognostic value of coronary artery calcium scoring for predicting atherosclerotic risk, some current models do not take coronary calcium into account, a speaker reported.

Over 20 years, CVD risk and CV risk factor prevalence was greater in Black Americans compared with white Americans, though the difference may have been mediated by social determinants of health, researchers reported.

Utilizing commercially available assays, researchers demonstrated the feasibility of evaluating the specific atherogenic contributions of lipoprotein(a) in cholesterol at the National Lipid Association Scientific Sessions.